Dapaconazole
Modify Date: 2025-08-25 12:31:51
Dapaconazole structure
|
Common Name | Dapaconazole | ||
|---|---|---|---|---|
| CAS Number | 1269726-67-1 | Molecular Weight | 415.236 | |
| Density | 1.4±0.1 g/cm3 | Boiling Point | 512.8±50.0 °C at 760 mmHg | |
| Molecular Formula | C19H15Cl2F3N2O | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 263.9±30.1 °C | |
Use of DapaconazoleDapaconazole, as an antifungal agent, inhibits sterol 14α-demethylase cytochrome P450 activity with an IC50 of 1.4 μM[1]. |
| Name | dapaconazole |
|---|---|
| Synonym | More Synonyms |
| Description | Dapaconazole, as an antifungal agent, inhibits sterol 14α-demethylase cytochrome P450 activity with an IC50 of 1.4 μM[1]. |
|---|---|
| Related Catalog | |
| Target |
Cytochrome P450 (CYP26):1.4 μM (IC50) |
| In Vitro | Dapaconazole inhibits sterol 14α-demethylase cytochrome P450 activity with an IC50 of 1.4 ± 0.3 μM[1]. |
| In Vivo | Dapaconazole (20 mg/kg; p.o.) shows that the bioavailability is 97.3 %[1]. Animal Model: Male beagle dogs[1] Dosage: 20 mg/kg (Pharmacokinetic Analysis) Administration: P.o. Result: Showed that the bioavailability was 97.3 %. |
| References |
| Density | 1.4±0.1 g/cm3 |
|---|---|
| Boiling Point | 512.8±50.0 °C at 760 mmHg |
| Molecular Formula | C19H15Cl2F3N2O |
| Molecular Weight | 415.236 |
| Flash Point | 263.9±30.1 °C |
| Exact Mass | 414.051361 |
| LogP | 5.30 |
| Vapour Pressure | 0.0±1.3 mmHg at 25°C |
| Index of Refraction | 1.565 |
| Storage condition | 2-8°C |
| 1-[2-(2,4-Dichlorophenyl)-2-{[4-(trifluoromethyl)benzyl]oxy}ethyl]-1H-imidazole |
| dapaconazole |
| H2976538CX |
| 1H-Imidazole, 1-[2-(2,4-dichlorophenyl)-2-[[4-(trifluoromethyl)phenyl]methoxy]ethyl]- |
| UNII:H2976538CX |